LONDON--(BUSINESS WIRE)--As developers of point of care (POC) molecular tests enhance their application scope to detect new disease markers, the POC molecular diagnostics market will present attractive opportunities. Market participants can enhance the utilization of POC molecular tests by improvising the existing tests and simultaneously focusing on R&D to develop innovative ways of detecting new disease markers.
